000 01256 a2200325 4500
005 20250517120631.0
264 0 _c20161109
008 201611s 0 0 eng d
022 _a1469-493X
024 7 _a10.1002/14651858.CD001347.pub2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAllen, Claire S
245 0 0 _aBisphosphonates for steroid-induced osteoporosis.
_h[electronic resource]
260 _bThe Cochrane database of systematic reviews
_cOct 2016
300 _aCD001347 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
650 0 4 _aAdult
650 0 4 _aBone Density Conservation Agents
_xtherapeutic use
650 0 4 _aDiphosphonates
_xtherapeutic use
650 0 4 _aGlucocorticoids
_xadverse effects
650 0 4 _aHumans
650 0 4 _aOsteoporosis
_xchemically induced
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aSpinal Fractures
_xprevention & control
700 1 _aYeung, James Hs
700 1 _aVandermeer, Ben
700 1 _aHomik, Joanne
773 0 _tThe Cochrane database of systematic reviews
_gvol. 10
_gp. CD001347
856 4 0 _uhttps://doi.org/10.1002/14651858.CD001347.pub2
_zAvailable from publisher's website
999 _c26486869
_d26486869